Cost-effectiveness and drug wastage of bevacizumab biosimilar with or without chemotherapy for platinum-resistant recurrent ovarian cancer-Reference-Cited by-同舟云学术

Cost-effectiveness and drug wastage of bevacizumab biosimilar with or without chemotherapy for platinum-resistant recurrent ovarian cancer

Published:2024-02-28 Issue:4 Volume:24 Page:541-549
ISSN:1473-7167
Container-title:Expert Review of Pharmacoeconomics & Outcomes Research
language:en
Short-container-title:Expert Review of Pharmacoeconomics & Outcomes Research

Author:

Lai Shih Ping¹,Wang Shyh-Yau²,Chan Agnes LF³,Leung John Hang⁴,Yip Hei-Tung⁵

Affiliation:

1. Department of Obstetrics and Gynecology, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan

2. Department of Radiology, An-Nan Hospital, China Medical University, Tainan, Taiwan

3. Department of Pharmacy, An-Nan Hospital, China Medical University, Tainan, Taiwan

4. Department of Obstetrics and Gynecology, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chiayi, Taiwan

5. Management Office for Health Data, Clinical Trial Research Center, China Medical University Hospital, Taichung, Taiwan

Funder

China Medical University

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737167.2024.2319605

Reference41 articles.

1. American cancer society. Available from: https://www.cancer.org/cancer/ovarian-cancer/about/key-statistics.html

2. Health Promotion Administration Ministry Of Health And Welfare. Available from: https://www.cancer.org/cancer/ovarian-cancer/about/key-statistics.html

3. Clinical Challenges in the Management of Malignant Ovarian Germ Cell Tumours

4. Neoadjuvant treatment for newly diagnosed advanced ovarian cancer: where do we stand and where are we going?

5. NCCN Guidelines Version 2. 2023 Ovarian cancer. National comprehensive cancer network. [cited 2023 Jan7]. Available from: https://www.nccn.org/professionals/physician_gls/pdf/ovarian.pdf

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High cost of chemotherapy for gynecologic malignancies;Japanese Journal of Clinical Oncology;2024-07-18